After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Although patients and the general public were identified as the primary audience, the researchers noted that AI-generated ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

OpenEvidence raises $210M on $3.5B valuation to expand AI-powered medical search and decision tools - SiliconANGLE ...

Most U.S. adults find the information to be at least somewhat reliable, new research shows. But experts say there is ...